Product
Olmesartan Medoxomil + Hydrochlorothiazide
2 clinical trials
2 indications
Indication
HealthyIndication
HypertensionClinical trial
Single-Dose Fed Bioequivalence Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets (40 mg/25 mg; Mylan) to Benicar HCT® Tablets (40 mg/25 mg; Sankyo) in Healthy VolunteersStatus: Completed, Estimated PCD: 2006-11-01
Clinical trial
Comparison of the Efficacy of Olmesartan Medoxomil Versus Nitrendipine on Systolic Blood Pressure in Elderly and Very Elderly Patients With Isolated Systolic HypertensionStatus: Completed, Estimated PCD: 2004-10-01